Detalles de la búsqueda
1.
Correction of modal DNA values obtained by microspectrophotometry and tests for their shifts.
J Natl Cancer Inst
; 60(6): 1251-8, 1978 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-650696
2.
Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer.
Eur J Cancer
; 30A(7): 959-64, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7946592
3.
A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
Anticancer Res
; 13(6B): 2361-5, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8135468
4.
Anterior communicating artery aneurysm in early childhood. Report of a case.
Surg Neurol
; 35(3): 224-9, 1991 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-1996452
5.
[Breast cancer surgery from the viewpoint of quality of life].
Gan To Kagaku Ryoho
; 15(9): 2692-9, 1988 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-3415267
6.
[Breast cancer and hormone therapy].
Gan To Kagaku Ryoho
; 14(10): 2830-6, 1987 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-2959203
7.
[Clinicopathological features of recurrent breast cancer].
Gan To Kagaku Ryoho
; 12(3 Pt 1): 412-20, 1985 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-4004278
8.
[Local forms of the treatment of recurrent breast cancer].
Gan To Kagaku Ryoho
; 15(4 Pt 2-2): 1318-24, 1988 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-3382201
9.
[Selection of therapeutic procedures according to the clinicopathological features of breast cancer].
Gan To Kagaku Ryoho
; 13(1): 37-45, 1986 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-2935084
10.
[End result of preoperative adjuvant chemotherapy with oral 5-FU dry syrup in gastric cancer].
Gan To Kagaku Ryoho
; 15(6): 1929-33, 1988 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-3382242
11.
[Clinical significance of a skin test (SU-PS) for immune responses in patients with gastrointestinal cancer treated with OK-432].
Gan To Kagaku Ryoho
; 13(11): 3229-35, 1986 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-3777960
12.
[Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study].
Gan To Kagaku Ryoho
; 20(1): 79-90, 1993 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-8422189
13.
[Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen].
Gan To Kagaku Ryoho
; 20(2): 247-58, 1993 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-8434963
14.
[Efficacy and safety of high dose NK 622 (toremifene citrate) in tamoxifen failed patients with breast cancer].
Gan To Kagaku Ryoho
; 20(1): 91-9, 1993 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-8422190
15.
[Preoperative immunochemotherapy for gastric cancer patients--immunomodulating effect of levamisole and lentinan on cell-mediated immunity and regional lymph node].
Gan To Kagaku Ryoho
; 9(6): 1052-60, 1982 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-7184439
16.
[Response to rechallenged tamoxifen of metastatic breast cancer relapsed after surgical adjuvant tamoxifen treatment].
Gan To Kagaku Ryoho
; 18(8): 1333-6, 1991 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-2069403
17.
[A prospective randomized trial comparing epirubicin and doxorubicin in advanced or recurrent breast cancer].
Gan To Kagaku Ryoho
; 13(12): 3498-507, 1986 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-3466574
18.
[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation].
Gan To Kagaku Ryoho
; 9(11): 1994-2004, 1982 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-6223590
19.
[Correlations between estrogen receptor and prognostic factors of patients with breast cancer. The Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan].
Gan To Kagaku Ryoho
; 20(14): 2171-6, 1993 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-8239682
20.
[Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
Gan To Kagaku Ryoho
; 15(6): 1863-71, 1988 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-3382238